These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 18633624)
1. Magnetic resonance imaging (MRI)-based indication for neoadjuvant treatment of rectal carcinoma and the surrogate endpoint CRM status. Strassburg J; Junginger T; Trinh T; Püttcher O; Oberholzer K; Heald RJ; Hermanek P Int J Colorectal Dis; 2008 Nov; 23(11):1099-107. PubMed ID: 18633624 [TBL] [Abstract][Full Text] [Related]
2. Cancer of the upper rectum. Bondeven P Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697137 [TBL] [Abstract][Full Text] [Related]
3. Risk factors for adverse outcome in patients with rectal cancer treated with an abdominoperineal resection in the total mesorectal excision trial. den Dulk M; Marijnen CA; Putter H; Rutten HJ; Beets GL; Wiggers T; Nagtegaal ID; van de Velde CJ Ann Surg; 2007 Jul; 246(1):83-90. PubMed ID: 17592295 [TBL] [Abstract][Full Text] [Related]
4. Long-term prognostic value of mesorectal grading after neoadjuvant chemoradiotherapy for rectal cancer. Madbouly KM; Hussein AM; Abdelzaher E Am J Surg; 2014 Sep; 208(3):332-41. PubMed ID: 24581995 [TBL] [Abstract][Full Text] [Related]
5. Optimised surgery (so-called TME surgery) and high-resolution MRI in the planning of treatment of rectal carcinoma. Strassburg J; Lewin A; Ludwig K; Kilian L; Linke J; Loy V; Knuth P; Püttcher O; Ruehl U; Stöckmann F; Hackenthal M; Hopfenmüller W; Huppertz A Langenbecks Arch Surg; 2007 Mar; 392(2):179-88. PubMed ID: 17279430 [TBL] [Abstract][Full Text] [Related]
6. Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trial. Lee JB; Kim HS; Jung I; Shin SJ; Beom SH; Chang JS; Koom WS; Kim TI; Hur H; Min BS; Kim NK; Park S; Jeong SY; Baek JH; Kim SH; Lim JS; Lee KY; Ahn JB Trials; 2020 Apr; 21(1):320. PubMed ID: 32264919 [TBL] [Abstract][Full Text] [Related]
7. Circumferential resection margin (CRM) positivity after MRI assessment and adjuvant treatment in 189 patients undergoing rectal cancer resection. Simpson GS; Eardley N; McNicol F; Healey P; Hughes M; Rooney PS Int J Colorectal Dis; 2014 May; 29(5):585-90. PubMed ID: 24651956 [TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance imaging in rectal cancer downstaged using neoadjuvant chemoradiation: accuracy of prediction of tumour stage and circumferential resection margin status. Kulkarni T; Gollins S; Maw A; Hobson P; Byrne R; Widdowson D Colorectal Dis; 2008 Jun; 10(5):479-89. PubMed ID: 18318754 [TBL] [Abstract][Full Text] [Related]
10. The circumferential resection margin in rectal carcinoma surgery. Hermanek P; Junginger T Tech Coloproctol; 2005 Dec; 9(3):193-9; discussion 199-200. PubMed ID: 16328130 [TBL] [Abstract][Full Text] [Related]
11. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report]. Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308 [No Abstract] [Full Text] [Related]
12. [The role of magnetic resonance imaging to select patients for preoperative treatment in rectal cancer]. Rödel C; Sauer R; Fietkau R Strahlenther Onkol; 2009 Aug; 185(8):488-92. PubMed ID: 19652930 [TBL] [Abstract][Full Text] [Related]
13. MRI-Based Use of Neoadjuvant Chemoradiotherapy in Rectal Carcinoma: Surgical Quality and Histopathological Outcome of the OCUM Trial. Kreis ME; Ruppert R; Kube R; Strassburg J; Lewin A; Baral J; Maurer CA; Sauer J; Winde G; Thomasmeyer R; Stelzner S; Bambauer C; Scheunemann S; Faedrich A; Junginger T; Hermanek P; Merkel S; Ann Surg Oncol; 2020 Feb; 27(2):417-427. PubMed ID: 31414295 [TBL] [Abstract][Full Text] [Related]
14. Quality of total mesorectal excision and depth of circumferential resection margin in rectal cancer: a matched comparison of the first 20 robotic cases. Barnajian M; Pettet D; Kazi E; Foppa C; Bergamaschi R Colorectal Dis; 2014 Aug; 16(8):603-9. PubMed ID: 24750995 [TBL] [Abstract][Full Text] [Related]
15. MAGNETIC RESONANCE IMAGING TO EVALUATE NEOADJUVANT THERAPY EFFECTS ON RECTAL CARCINOMA. Sofić A; Vukobrat-Bijedić Z; Husić-Selimović A; Šehović N; Buija D; Eminagić D; Banjin M; Đuran A Acta Clin Croat; 2015 Sep; 54(3):303-8. PubMed ID: 26666099 [TBL] [Abstract][Full Text] [Related]
16. Robotic versus laparoscopic sphincter-saving total mesorectal excision for mid or low rectal cancer in male patients after neoadjuvant chemoradiation therapy: comparison of long-term outcomes. Asoglu O; Tokmak H; Bakir B; Aliyev V; Saglam S; Iscan Y; Bademler S; Meric S J Robot Surg; 2020 Jun; 14(3):393-399. PubMed ID: 31313071 [TBL] [Abstract][Full Text] [Related]
17. Transanal total mesorectal excision (TaTME) versus laparoscopic TME for MRI-defined low rectal cancer: a propensity score-matched analysis of oncological outcomes. Roodbeen SX; Penna M; Mackenzie H; Kusters M; Slater A; Jones OM; Lindsey I; Guy RJ; Cunningham C; Hompes R Surg Endosc; 2019 Aug; 33(8):2459-2467. PubMed ID: 30350103 [TBL] [Abstract][Full Text] [Related]
18. The circumferential resection margins status: A comparison of robotic, laparoscopic and open total mesorectal excision for mid and low rectal cancer. de Jesus JP; Valadão M; de Castro Araujo RO; Cesar D; Linhares E; Iglesias AC Eur J Surg Oncol; 2016 Jun; 42(6):808-12. PubMed ID: 27038996 [TBL] [Abstract][Full Text] [Related]
19. Assessment of mesorectal fascia status in MRI compared with circumferential resection margin after total mesorectal excision and predictors of involved margins. Emile SH; Horesh N; Freund MR; Parlade A; Nagarajan A; Garoufalia Z; Gefen R; Silva-Alvarenga E; Dasilva G; Wexner SD Surgery; 2022 Oct; 172(4):1085-1092. PubMed ID: 35970606 [TBL] [Abstract][Full Text] [Related]
20. Is it time to rethink the rule of total mesorectal excision? A prospective radiological and pathological study in 49 consecutive patients with mid-rectal cancer. Guedj N; Zappa M; Maggiori L; Bertin C; Hennequin C; Panis Y Colorectal Dis; 2016 Sep; 18(9):O314-21. PubMed ID: 27381492 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]